Keyphrases
Acute Myeloid Leukemia
100%
Concanavalin A (Con A)
100%
Cytarabine
100%
Potential Biomarkers
100%
Ara-C
100%
Acute Myeloid Leukemia Cells
30%
Rational Choice
10%
Mass Spectrometry
10%
Intensive Chemotherapy
10%
Glycomics
10%
Treatment Protocol
10%
Mannosylation
10%
Lectin
10%
Blood Cells
10%
High-level Expression
10%
Publicly Available
10%
Resistant Cells
10%
Working Diagnosis
10%
Anthracyclines
10%
Leukemia Cell Lines
10%
Optimal Treatment
10%
Therapy-resistant
10%
5-year Survival
10%
Primary Refractory Disease
10%
Glycosylation
10%
Novel Biomarkers
10%
Chemotherapy Protocols
10%
Myeloid Lineage
10%
Patient-derived
10%
N-glycan
10%
Leukemia Data
10%
Glycosylation Profile
10%
High-mannose Glycans
10%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Acute Myeloid Leukemia
100%
Concanavalin A
100%
Cytarabine
100%
Glycan
22%
Disease
11%
Malignant Neoplasm
11%
Anthracycline
11%
Chemotherapy
11%
Survival Rate
11%
Mannose
11%
Lectin
11%
Immunology and Microbiology
Myeloid
100%
Concanavalin A
100%
Glycan
22%
Leukemia Cell
22%
Glycosylation
22%
Survival Rate
11%
Lineages
11%
Lectin
11%
Acute Myeloid Leukemia Cell Line
11%
Biochemistry, Genetics and Molecular Biology
Cytarabine
100%
Mannose
10%
Neuroscience
Glycan
20%
Glycosylation
20%